#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

A Viral microRNA Cluster Strongly Potentiates the Transforming Properties of a Human Herpesvirus


Epstein-Barr virus (EBV), an oncogenic human herpesvirus, induces cell proliferation after infection of resting B lymphocytes, its reservoir in vivo. The viral latent proteins are necessary for permanent B cell growth, but it is unknown whether they are sufficient. EBV was recently found to encode microRNAs (miRNAs) that are expressed in infected B cells and in some EBV-associated lymphomas. EBV miRNAs are grouped into two clusters located either adjacent to the BHRF1 gene or in introns contained within the viral BART transcripts. To understand the role of the BHRF1 miRNA cluster, we have constructed a virus mutant that lacks all its three members (Δ123) and a revertant virus. Here we show that the B cell transforming capacity of the Δ123 EBV mutant is reduced by more than 20-fold, relative to wild type or revertant viruses. B cells exposed to the knock-out virus displayed slower growth, and exhibited a two-fold reduction in the percentage of cells entering the cell cycle S phase. Furthermore, they displayed higher latent gene expression levels and latent protein production than their wild type counterparts. Therefore, the BHRF1 miRNAs accelerate B cell expansion at lower latent gene expression levels. Thus, this miRNA cluster simultaneously enhances expansion of the virus reservoir and reduces the viral antigenic load, two features that have the potential to facilitate persistence of the virus in the infected host. Thus, the EBV BHRF1 miRNAs may represent new therapeutic targets for the treatment of some EBV-associated lymphomas.


Vyšlo v časopise: A Viral microRNA Cluster Strongly Potentiates the Transforming Properties of a Human Herpesvirus. PLoS Pathog 7(2): e32767. doi:10.1371/journal.ppat.1001294
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1001294

Souhrn

Epstein-Barr virus (EBV), an oncogenic human herpesvirus, induces cell proliferation after infection of resting B lymphocytes, its reservoir in vivo. The viral latent proteins are necessary for permanent B cell growth, but it is unknown whether they are sufficient. EBV was recently found to encode microRNAs (miRNAs) that are expressed in infected B cells and in some EBV-associated lymphomas. EBV miRNAs are grouped into two clusters located either adjacent to the BHRF1 gene or in introns contained within the viral BART transcripts. To understand the role of the BHRF1 miRNA cluster, we have constructed a virus mutant that lacks all its three members (Δ123) and a revertant virus. Here we show that the B cell transforming capacity of the Δ123 EBV mutant is reduced by more than 20-fold, relative to wild type or revertant viruses. B cells exposed to the knock-out virus displayed slower growth, and exhibited a two-fold reduction in the percentage of cells entering the cell cycle S phase. Furthermore, they displayed higher latent gene expression levels and latent protein production than their wild type counterparts. Therefore, the BHRF1 miRNAs accelerate B cell expansion at lower latent gene expression levels. Thus, this miRNA cluster simultaneously enhances expansion of the virus reservoir and reduces the viral antigenic load, two features that have the potential to facilitate persistence of the virus in the infected host. Thus, the EBV BHRF1 miRNAs may represent new therapeutic targets for the treatment of some EBV-associated lymphomas.


Zdroje

1. RickinsonAB

KieffE

2007 Epstein-Barr virus,

KnipeDM

HowleyPM

GriffinDE

LambRA

MartinMA

RoizmanB

StrausSE

Fields Virology Philadelphia Lippincott Williams & Wilkins 2655 2700

2. RickinsonAB

CallanMF

AnnelsNE

2000 T-cell memory: lessons from Epstein-Barr virus infection in man. Philos Trans R Soc Lond B Biol Sci 355 391 400

3. HammerschmidtW

SudgenB

1989 Genetic analysis of immortalizing functions of Epstein-Barr virus in human B-lymphocytes. Nature 340 393 397

4. CohenJI

WangF

MannickJ

KieffE

1989 Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc Natl Acad Sci U S A 86 9558 9562

5. MannickJB

CohenJI

BirkenbachM

MarchiniA

KieffE

1991 The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J Virol 65 6826 6837

6. KayeKM

IzumiKM

KieffE

1993 Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci U S A 90 9150 9154

7. HummeS

ReisbachG

FeederleR

DelecluseHJ

BoussetK

2003 The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold. Proc Natl Acad Sci U S A 100 10989 10994

8. LernerMR

AndrewsNC

MillerG

SteitzJA

1981 Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A 78 805 809

9. PfefferS

ZavolanM

GrasserFA

ChienM

RussoJJ

2004 Identification of virus-encoded microRNAs. Science 304 734 746

10. CaiX

SchaferA

LuS

BilelloJP

DesrosiersRC

2006 Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog 2 e23

11. CosmopoulosK

PegtelM

HawkinsJ

MoffettH

NovinaC

2009 Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. J Virol 83 2357 2367

12. HutzingerR

FeederleR

MrazekJ

SchiefermeierN

BalwierzPJ

2009 Expression and processing of a small nucleolar RNA from the Epstein-Barr virus genome. PLoS Pathog 5 e1000547

13. BartelDP

2004 MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 281 297

14. KieffE

RickinsonAB

2007 Epstein-Barr virus and its replication.

KnipeDM

HowleyPM

GriffinDE

LambRA

MartinMA

RoizmanB

StrausSE

Fields Virology Philadelphia Lippincott Williams & Wilkins 2603 2654

15. XingL

KieffE

2007 Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replication. J Virol 81 9967 9975

16. NeuhierlB

DelecluseHJ

2005 Molecular genetics of DNA viruses: recombinant virus technology. Methods Mol Biol 292 353 370

17. AubinJ

DaviF

Nguyen-SalomonF

LeboeufD

DebertC

1995 Description of a novel FR1 IgH PCR strategy and its comparison with three other strategies for the detection of clonality in B cell malignancies. Leukemia 9 471 479

18. KellyGL

LongHM

StylianouJ

ThomasWA

LeeseA

2009 An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link. PLoS Pathog 5 e1000341

19. PfefferS

SewerA

Lagos-QuintanaM

SheridanR

SanderC

2005 Identification of microRNAs of the herpesvirus family. Nat Methods 2 269 276

20. CullenBR

2009 Viral and cellular messenger RNA targets of viral microRNAs. Nature 457 421 425

21. BarthS

PfuhlT

MamianiA

EhsesC

RoemerK

2008 Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5. Nucleic Acids Res 36 666 675

22. UmbachJL

KramerMF

JurakI

KarnowskiHW

CoenDM

2008 MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 454 780 783

23. MurphyE

VanicekJ

RobinsH

ShenkT

LevineAJ

2008 Suppression of immediate-early viral gene expression by herpesvirus-coded microRNAs: implications for latency. Proc Natl Acad Sci U S A 105 5453 5458

24. LeiX

BaiZ

YeF

XieJ

KimCG

2010 Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA. Nat Cell Biol 12 193 199

25. Stern-GinossarN

ElefantN

ZimmermannA

WolfDG

SalehN

2007 Host immune system gene targeting by a viral miRNA. Science 317 376 381

26. XiaT

O'HaraA

AraujoI

BarretoJ

CarvalhoE

2008 EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res 68 1436 1442

27. HutchingsIA

TierneyRJ

KellyGL

StylianouJ

RickinsonAB

2006 Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines. J Virol 80 10700 10711

28. PrattZL

KuzembayevaM

SenguptaS

SugdenB

2009 The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines. Virology 386 387 397

29. HafnerM

LandthalerM

BurgerL

KhorshidM

HausserJ

2010 Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141 129 141

30. GrahamFL

SmileyJ

RussellWC

NairnR

1977 Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36 59 74

31. ShawG

MorseS

AraratM

GrahamFL

2002 Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. Faseb J 16 869 871

32. PulvertaftRJV

1964 Cytology of Burkitt's lymphoma (African lymphoma). Lancet 1 238 240

33. TakadaK

HorinouchiK

OnoY

AyaT

OsatoT

1991 An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA. Virus Genes 5 147 156

34. ClementsGB

KleinG

PoveyS

1975 Production by EBV infection of an EBNA-positive subline from an EBNA-negative human lymphoma cell line without detectable EBV DNA. Int J Cancer 16 125 133

35. HayflickL

1965 The Limited in Vitro Lifetime of Human Diploid Cell Strains. Exp Cell Res 37 614 636

36. DelecluseHJ

HilsendegenT

PichD

ZeidlerR

HammerschmidtW

1998 Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc Natl Acad Sci U S A 95 8245 8250

37. GriffinBE

BjorckE

BjursellG

LindahlT

1981 Sequence complexity of circular Epstein-Bar virus DNA in transformed cells. J Virol 40 11 19

38. FeederleR

BannertH

LipsH

Muller-LantzschN

DelecluseHJ

2009 The Epstein-Barr virus alkaline exonuclease BGLF5 serves pleiotropic functions in virus replication. J Virol 83 4952 4962

39. ChenC

RidzonDA

BroomerAJ

ZhouZ

LeeDH

2005 Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33 e179

40. BellAI

GrovesK

KellyGL

Croom-CarterD

HuiE

2006 Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays. J Gen Virol 87 2885 2890

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2011 Číslo 2
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#